Soleus Capital Management, L.P.
Filing Date
Global Rank
#1,056
/ 8,603
▲ 60
· as of Mar 2026
Top Industry
Biotechnology
56.6%
3Y Alpha vs SPY
+9.6%
Period ended 3 months ago
Filed May 14, 2026 · 56d
25 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+47.4%
SPY
+76.5%
Annualised alpha
-7.0%
Max drawdown
−51.5%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
93 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
11.8%
+1.8 pts
Top 5
32.2%
+1.0 pts
Top 10
49.4%
+1.3 pts
HHI
371
Diversified+27
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $2,514,062,477 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GERN | Geron Corp | +18,218,659 | 41,508,659 | $61,847,901 | |
| CERS | Cerus Corp | +6,753,700 | 10,753,700 | $19,571,734 | |
| NVCR | NovoCure Ltd | +1,961,726 | 10,492,391 | $114,367,061 | |
| BBNX | Beta Bionics, Inc. | +1,819,936 | 4,354,501 | $43,632,100 | |
| VCEL | Vericel Corp | +1,785,079 | 2,549,079 | $82,003,871 | |
| EOLS | Evolus, Inc. | +1,175,360 | 2,245,360 | $9,228,429 | |
| TGTX | Tg Therapeutics, Inc. | +890,007 | 4,029,319 | $133,853,977 | |
| LUNG | Pulmonx Corp | +750,000 | 2,788,323 | $3,596,936 | |
| TRVI | Trevi Therapeutics, Inc. | +720,000 | 1,620,000 | $19,326,600 | |
| ALKS | Alkermes plc. | +648,500 | 1,970,864 | $69,689,751 | |
| URGN | UroGen Pharma Ltd. | +577,000 | 727,000 | $13,071,460 | |
| EWTX | Edgewise Therapeutics, Inc. | +539,915 | 1,449,915 | $45,672,322 | |
| TNGX | Tango Therapeutics, Inc. | +440,000 | 450,000 | $9,414,000 | |
| PODD | Insulet Corp | +412,500 | 562,500 | $118,035,000 | |
| ANIP | Ani Pharmaceuticals Inc | +334,000 | 820,243 | $63,076,686 | |
| VCYT | Veracyte, Inc. | +309,912 | 319,912 | $10,304,365 | |
| INSP | Inspire Medical Systems, Inc. | +276,900 | 576,299 | $29,725,502 | |
| NPCE | NeuroPace Inc | +228,999 | 2,932,207 | $38,558,522 | |
| KRYS | Krystal Biotech, Inc. | +212,028 | 1,153,087 | $297,865,433 | |
| UTHR | UNITED THERAPEUTICS Corp | +127,187 | 187,187 | $110,998,147 | |
| INBX | Inhibrx Biosciences, Inc. | +106,000 | 131,000 | $8,807,130 | |
| ORGO | Organogenesis Holdings Inc. | +100,000 | 10,085,951 | $23,903,703 | |
| NTRA | Natera, Inc. | +99,000 | 119,000 | $23,798,810 | |
| KIDS | Orthopediatrics Corp | +90,000 | 615,447 | $9,767,143 | |
| JSPR | Jasper Therapeutics, Inc. | +76,312 | 276,312 | $242,049 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| DXCM | Dexcom Inc | −1,157,094 | 140,000 | $8,792,000 | |
| IMVT | Immunovant, Inc. | −880,000 | 230,000 | $5,713,200 | |
| ELVN | Enliven Therapeutics, Inc. | −794,131 | 230,869 | $9,050,064 | |
| BMRN | Biomarin Pharmaceutical Inc | −669,428 | 650,572 | $36,750,812 | |
| TWST | Twist Bioscience Corp | −635,173 | 1,226,629 | $58,289,410 | |
| AXGN | Axogen, Inc. | −527,685 | 679,170 | $22,500,902 | |
| CELC | Celcuity Inc. | −523,880 | 1,284,378 | $146,598,904 | |
| SNDX | Syndax Pharmaceuticals Inc | −520,202 | 1,726,908 | $40,340,570 | |
| RIGL | Rigel Pharmaceuticals Inc | −290,034 | 10,000 | $270,400 | |
| NRIX | Nurix Therapeutics, Inc. | −281,231 | 938,163 | $14,541,526 | |
| RCUS | Arcus Biosciences, Inc. | −260,000 | 451,983 | $9,762,832 | |
| NEO | Neogenomics Inc | −252,504 | 175,000 | $1,298,500 | |
| MBX | MBX Biosciences, Inc. | −230,003 | 178,897 | $5,340,075 | |
| PCVX | Vaxcyte, Inc. | −223,486 | 385,472 | $22,399,777 | |
| ORKA | Oruka Therapeutics, Inc. | −185,000 | 5,000 | $245,250 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −173,308 | 400,306 | $36,980,268 | |
| GMED | Globus Medical Inc | −157,533 | 729,467 | $62,850,876 | |
| CGON | CG Oncology, Inc. | −150,000 | 20,000 | $1,353,600 | |
| ANAB | Anaptysbio, Inc | −129,000 | 6,000 | $221,839 | |
| TYRA | Tyra Biosciences, Inc. | −115,000 | 10,000 | $383,000 | |
| COGT | Cogent Biosciences, Inc. | −110,000 | 10,000 | $384,900 | |
| SEPN | Septerna, Inc. | −108,368 | 275,000 | $6,608,250 | |
| NSPR | InspireMD, Inc. | −104,292 | 1,045,708 | $1,704,504 | |
| ZYME | Zymeworks Inc. | −90,000 | 10,000 | $250,400 | |
| KNSA | Kiniksa Pharmaceuticals International, plc | −65,647 | 521,353 | $25,103,146 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
25 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IMUX | Immunic, Inc. | 4,500,000 | $49,950,000 | |
| INDV | Indivior Pharmaceuticals, Inc. | 1,274,000 | $38,831,520 | |
| PGNY | Progyny, Inc. | 2,067,000 | $35,097,660 | |
| MRK | Merck & Co., Inc. | 203,000 | $24,418,870 | |
| ICLR | Icon PLC | 192,000 | $21,246,720 | |
| CNTX | Context Therapeutics Inc. | 6,963,141 | $18,243,429 | |
| VIR | Vir Biotechnology, Inc. | 2,002,000 | $17,937,920 | |
| XENE | Xenon Pharmaceuticals Inc. | 292,000 | $16,979,800 | |
| TVTX | Travere Therapeutics, Inc. | 546,000 | $16,221,660 | |
| TNDM | Tandem Diabetes Care Inc | 783,000 | $15,010,110 | |
| CORT | Corcept Therapeutics Inc | 285,531 | $11,509,754 | |
| SOPH | SOPHiA GENETICS SA | 1,850,000 | $9,157,500 | |
| BDSX | Biodesix Inc | 416,599 | $6,040,685 | |
| RLMD | Relmada Therapeutics, Inc. | 842,106 | $5,861,057 | |
| CGEM | Cullinan Therapeutics, Inc. | 410,200 | $5,828,942 | |
| LRMR | Larimar Therapeutics, Inc. | 1,066,960 | $4,801,320 | |
| ETON | Eton Pharmaceuticals, Inc. | 166,381 | $4,106,283 | |
| SABS | SAB Biotherapeutics, Inc. | 1,050,000 | $4,021,500 | |
| PRCT | PROCEPT BioRobotics Corp | 160,000 | $4,001,600 | |
| TECX | Tectonic Therapeutic, Inc. | 121,684 | $3,761,252 | |
| IOVA | Iovance Biotherapeutics, Inc. | 1,000,000 | $3,510,000 | |
| MSLE | Satellos Bioscience Inc. | 414,359 | $2,332,841 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 28,479 | $1,785,633 | |
| CTMX | CytomX Therapeutics, Inc. | 300,000 | $1,410,000 | |
| RAPP | Rapport Therapeutics, Inc. | 10,000 | $312,900 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
23 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| FOLD | AMICUS THERAPEUTICS, INC. | 5,207,284 | $74,151,724 | |
| GSK | GSK plc | 639,000 | $31,336,560 | |
| NBIX | Neurocrine Biosciences Inc | 175,982 | $24,959,527 | |
| TFX | Teleflex Inc | 190,000 | $23,187,600 | |
| CAPR | Capricor Therapeutics, Inc. | 646,390 | $18,654,815 | |
| THC | Tenet Healthcare Corp | 92,500 | $18,381,600 | |
| TERN | Terns Pharmaceuticals, Inc. | 212,710 | $8,593,484 | |
| ERAS | Erasca, Inc. | 2,162,162 | $8,043,242 | |
| BLTE | Belite Bio, Inc | 40,354 | $6,455,025 | |
| ABVX | Abivax S.A. | 45,000 | $6,068,475 | |
| MLTX | MoonLake Immunotherapeutics | 400,000 | $5,272,000 | |
| CALC | CalciMedica, Inc. | 683,904 | $4,506,927 | |
| VKTX | Viking Therapeutics, Inc. | 70,000 | $2,462,600 | |
| QDEL | QuidelOrtho Corp | 75,000 | $2,142,000 | |
| ACLX | Arcellx, Inc. | 30,000 | $1,956,000 | |
| OLMA | Olema Pharmaceuticals, Inc. | 69,874 | $1,746,850 | |
| BCAX | Bicara Therapeutics Inc. | 100,000 | $1,683,000 | |
| KOD | Kodiak Sciences Inc. | 60,000 | $1,677,600 | |
| GRAL | GRAIL, Inc. | 11,000 | $941,490 | |
| GUTS | Fractyl Health, Inc. | 400,000 | $880,000 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | 500 | $291,170 | |
| DYN | Dyne Therapeutics, Inc. | 10,000 | $195,600 | |
| DCTH | Delcath Systems, Inc. | 10,000 | $101,000 | |
| No positions match the current search. | ||||
93 positions ·
$2,514,062,477 total
· as of Mar 31, 2026
Showing 1–50
of 93 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| KRYS |
Krystal Biotech, Inc.
Healthcare
|
Added | 1,153,087 | $297,865,433 | 11.85% | |
| CELC |
Celcuity Inc.
Healthcare
|
Reduced | 1,284,378 | $146,598,904 | 5.83% | |
| TGTX |
Tg Therapeutics, Inc.
Healthcare
|
Added | 4,029,319 | $133,853,977 | 5.32% | |
| PODD |
Insulet Corp
Healthcare
|
Added | 562,500 | $118,035,000 | 4.69% | |
| NVCR |
NovoCure Ltd
Healthcare
|
Added | 10,492,391 | $114,367,061 | 4.55% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Added | 187,187 | $110,998,147 | 4.42% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Reduced | 330,517 | $106,489,272 | 4.24% | |
| VCEL |
Vericel Corp
Healthcare
|
Added | 2,549,079 | $82,003,871 | 3.26% | |
| ALKS |
Alkermes plc.
Healthcare
|
Added | 1,970,864 | $69,689,751 | 2.77% | |
| ANIP |
Ani Pharmaceuticals Inc
Healthcare
|
Added | 820,243 | $63,076,686 | 2.51% | |
| GMED |
Globus Medical Inc
Healthcare
|
Reduced | 729,467 | $62,850,876 | 2.50% | |
| GERN |
Geron Corp
Healthcare
|
Added | 41,508,659 | $61,847,901 | 2.46% | |
| TWST |
Twist Bioscience Corp
Healthcare
|
Reduced | 1,226,629 | $58,289,410 | 2.32% | |
| IMUX |
Immunic, Inc.
Healthcare
|
NEW | 4,500,000 | $49,950,000 | 1.99% | |
| EWTX |
Edgewise Therapeutics, Inc.
Healthcare
|
Added | 1,449,915 | $45,672,322 | 1.82% | |
| BBNX |
Beta Bionics, Inc.
Healthcare
|
Added | 4,354,501 | $43,632,100 | 1.74% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Added | 131,650 | $43,559,035 | 1.73% | |
| SNDX |
Syndax Pharmaceuticals Inc
Healthcare
|
Reduced | 1,726,908 | $40,340,570 | 1.60% | |
| INDV |
Indivior Pharmaceuticals, Inc.
Healthcare
|
NEW | 1,274,000 | $38,831,520 | 1.54% | |
| NPCE |
NeuroPace Inc
Healthcare
|
Added | 2,932,207 | $38,558,522 | 1.53% | |
| LIVN |
LivaNova PLC
Healthcare
|
Added | 582,500 | $37,023,700 | 1.47% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 400,306 | $36,980,268 | 1.47% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 650,572 | $36,750,812 | 1.46% | |
| PGNY |
Progyny, Inc.
Healthcare
|
NEW | 2,067,000 | $35,097,660 | 1.40% | |
| INSP |
Inspire Medical Systems, Inc.
Healthcare
|
Added | 576,299 | $29,725,502 | 1.18% | |
| FOCL |
Edap Tms SA
Healthcare
|
Held | 7,309,254 | $27,190,424 | 1.08% | |
| KNSA |
Kiniksa Pharmaceuticals International, plc
Healthcare
|
Reduced | 521,353 | $25,103,146 | 1.00% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
NEW | 203,000 | $24,418,870 | 0.97% | |
| ORGO |
Organogenesis Holdings Inc.
Healthcare
|
Added | 10,085,951 | $23,903,703 | 0.95% | |
| NTRA |
Natera, Inc.
Healthcare
|
Added | 119,000 | $23,798,810 | 0.95% | |
| AXGN |
Axogen, Inc.
Healthcare
|
Reduced | 679,170 | $22,500,902 | 0.90% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
Reduced | 385,472 | $22,399,777 | 0.89% | |
| ICLR |
Icon PLC
Healthcare
|
NEW | 192,000 | $21,246,720 | 0.85% | |
| PHVS |
Pharvaris N.V.
Healthcare
|
Held | 702,052 | $19,832,969 | 0.79% | |
| CERS |
Cerus Corp
Healthcare
|
Added | 10,753,700 | $19,571,734 | 0.78% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Added | 1,620,000 | $19,326,600 | 0.77% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Held | 10,875,000 | $18,270,000 | 0.73% | |
| CNTX |
Context Therapeutics Inc.
Healthcare
|
NEW | 6,963,141 | $18,243,429 | 0.73% | |
| VIR |
Vir Biotechnology, Inc.
Healthcare
|
NEW | 2,002,000 | $17,937,920 | 0.71% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
NEW | 292,000 | $16,979,800 | 0.68% | |
| TVTX |
Travere Therapeutics, Inc.
Healthcare
|
NEW | 546,000 | $16,221,660 | 0.65% | |
| TNDM |
Tandem Diabetes Care Inc
Healthcare
|
NEW | 783,000 | $15,010,110 | 0.60% | |
| NRIX |
Nurix Therapeutics, Inc.
Healthcare
|
Reduced | 938,163 | $14,541,526 | 0.58% | |
| URGN |
UroGen Pharma Ltd.
Healthcare
|
Added | 727,000 | $13,071,460 | 0.52% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
Added | 293,500 | $11,766,415 | 0.47% | |
| CORT |
Corcept Therapeutics Inc
Healthcare
|
NEW | 285,531 | $11,509,754 | 0.46% | |
| JBIO |
Jade Biosciences, Inc.
Healthcare
|
Held | 796,744 | $11,194,253 | 0.45% | |
| VCYT |
Veracyte, Inc.
Healthcare
|
Added | 319,912 | $10,304,365 | 0.41% | |
| IVVD |
Invivyd, Inc.
Healthcare
|
Held | 7,708,727 | $10,021,345 | 0.40% | |
| CCCC |
C4 Therapeutics, Inc.
Healthcare
|
Held | 3,803,942 | $10,004,367 | 0.40% |